HTR2A and insomnia: It can be seen that treatment with MSEOs effectively inhibited the decrease in 5HT-2A and 5HT-1A levels in mice exhibiting PCPA-induced insomnia, maintaining the levels of 5HT-2A and 5HT-1A in the mice at normal levels.